Editorial. Discusses the potential role for rifampin in successful treatment of staphylococcal device infections caused by staphylococcus. Reference to study by Zimmerli et al in the same issue; Background on rifampin; Use of an antimicrobial class called quinolones; Combination of quinolone and rifampin, which may offer a unique therapeutic approach to the treatment of prosthetic device infections.